Studies of post-mortem tissue have shown that the location of fibrillar tau deposits, called neurofibrillary tangles (NFT), matches closely with regions of massive neuronal death 1,2 , severe cytological abnormalities 3 , and markers of caspase activation and apoptosis [4] [5] [6] , leading to the idea that tangles cause neurodegeneration in Alzheimer's disease and tau-related frontotemporal dementia. However, using in vivo multiphoton imaging to observe tangles and activation of executioner caspases in living tau transgenic mice (Tg4510 strain), we find the opposite: caspase activation occurs first, and precedes tangle formation by hours to days. New tangles form within a day. After a new tangle forms, the neuron remains alive and caspase activity seems to be suppressed. Similarly, introduction of wild-type 4-repeat tau (tau-4R) into wild-type animals triggered caspase activation, tau truncation and tau aggregation. Adeno-associated virus-mediated expression of a construct mimicking caspase-cleaved tau into wild-type mice led to the appearance of intracellular aggregates, tangle-related conformational-and phospho-epitopes, and the recruitment of full-length endogenous tau to the aggregates. On the basis of these data, we propose a new model in which caspase activation cleaves tau to initiate tangle formation, then truncated tau recruits normal tau to misfold and form tangles. Because tangle-bearing neurons are long-lived, we suggest that tangles are 'off pathway' to acute neuronal death. Soluble tau species, rather than fibrillar tau, may be the critical toxic moiety underlying neurodegeneration.
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To test the hypothesis that neurofibrillary tangles are a marker of cell injury or death, we used in vivo multiphoton imaging through a craniotomy, with topical application of thioflavin S to detect tangles and a fluorescent dye that binds to activated caspases, in Tg4510 tau transgenic mice that develop both tangles and substantial neuronal loss by 7 months of age [7] [8] [9] [10] . We expected relatively few cells to have active caspases at any moment, and indeed relatively few neurons (under 1% of all neurons) were observed to be caspase-positive at any imaging session. Even though tangles occupied only 15% of neurons in the superficial neocortical region imaged at this age (Supplementary Fig. 1a) , caspase-positive neurons were overwhelmingly likely (87.6%) to be in a tangle-bearing neuron ( Supplementary Fig. 1c) , confirming a close relationship between tangles and apoptosisrelated markers. On the other hand, caspase activation is rare: only a few percent of tangles are caspase-positive and well over 90% of tangle-containing neurons did not contain observable caspase activation ( Supplementary Fig. 1b ). We were interested in the fate of neurons that contain tangles, and especially in the fate of both the caspase-positive, tangle-positive neurons and the extremely rare caspase-positive, tangle-negative neurons, reasoning that these might represent a subclass of neurons undergoing neurodegeneration.
We identified over 500 tangle-bearing neurons in four (7-9 months old) Tg4510 mice, and carried out repeated imaging of these mice 2-5 days later, re-identifying the neurons in the initial imaging session by their location and proximity to fiduciary markers such as blood vessels. All of the tangle-bearing neurons followed were still present 2-5 days later. In the same animals, we identified 20 neurons that were caspase-positive and tangle-positive at the first imaging sessions. Caspase-positive neurons with tangles were also universally present 2-5 days later ( Fig. 1 ) (although we were unable to continue to monitor caspase activation in these cells because the caspase dye fades quickly). Post-mortem histological studies confirmed that, in the cortex, all tangles were present in neurons with an intact nucleus. Thus, the presence of a tangle, even a tangle in a neuron containing caspase activation, was not associated with acute toxicity.
We next focused on the infrequent neurons that were caspasepositive and tangle-negative (as defined by thioflavin S) during the initial imaging session. Because these neurons were quite rare, rather than imaging randomly selected fields we sought out caspasepositive, tangle-negative cells and noted their location. In three animals, in over 24 imaging sites we found 22 such neurons. Unexpectedly, repeat imaging 1 day later showed that a new tangle had formed in 20 (91%) of these 22 cells sometime in the 24 h period after the first imaging session (Fig. 2a-c) . We repeated this experiment, extensively imaging four additional mice, who received topically, along with the other markers, a solution of Hoechst to estimate the number of neurons per volume. We found 19 caspasepositive, tangle-negative neurons, and the next day 16 of these neurons had a new tangle (85%). Taken together (Fig. 2d) , in seven animals and 56 imaging sites, we observed 41 caspase-positive, tangle-negative neurons; 36 of these developed a tangle within 24 h (88%). We confirmed these observations with an alternative dye to image tangles, X-34 (refs 11, 12) , a fluorescent derivative of Congo Red that can be administered systemically ( Supplementary Fig. 2 ) and found similarly that caspase-positive, X-34-negative cells on day 1 develop tangles within a day. By contrast to the observation that 88% of caspasepositive tangle-negative cells develop a tangle in the next 24 h, only 1.7% of Hoechst-positive neurons that did not have caspase activation in the first imaging session were found to have a new tangle on reimaging 1 day later. We interpret these few cells as ones in which we missed the caspase activation period, indicating that it may last less than 24 h. This finding strongly indicates that new tangles form in less than a day, and that caspase activation precedes tangle formation. Because essentially all tangles are 'born' in a caspase-positive neuron, but (at any moment) .90% of tangle-containing neurons are not caspase-positive, we suggest that tangle-bearing cells survive the initial caspase attack and become caspase-negative. We attempted to image caspase activation repeatedly over time, but could not successfully remove the imaging coverslip to re-apply the caspase indicator reagent on subsequent imaging sessions. Unlike thioflavin S, which has a long half-life in the neuropil and remains available for imaging 24 h after application, the caspase indicator is not present at later imaging sessions.
We never observed a caspase-positive neuron in 48 imaging sites of six wild-type mice or two APP (amyloid precursor protein)-overexpressing mice. We therefore considered the possibility that the soluble P301L tau expression in Tg4510 mice led to caspase activation independently of the presence of a tangle. To test this hypothesis we examined caspase activation in tangle-bearing neurons, in the presence or absence of soluble tau expression. The Tg4510 mice are designed with a regulatable promoter, in which transgene expression can be suppressed with doxycycline. We treated 7-8-month-old animals with doxycycline and examined the presence of tangles and activation of caspases at baseline (n 5 6 transgenic and n 5 2 wild-type animals), or after a brief (2 weeks, n 5 2 transgenic and n 5 2 wild-type animals) or long (6 weeks, n 5 4 transgenic and n 5 2 wild-type animals) doxycycline treatment, by analysing random sites throughout the imaging volume.
Transgene suppression reduced the incidence of caspase activation in tangle-bearing cells in a time dependent fashion from 5-6% at baseline to 0.3% after 6 weeks, a reduction of nearly 20 fold (Supplementary Fig. 3 ). As observed previously 7 , innumerable tangles remain after 6 weeks of transgene suppression, indicating that they are stable and long-lived aggregates. No caspase-positive, tanglenegative cells were observed after transgene suppression. These data indicate that soluble tau molecules, rather than tangles, are upstream of caspase activation.
Caspases cleave tau preferentially at aspartate 421 (D421), creating a truncated molecule that can be recognized by neoepitope-specific antibodies 13, 14 . Caspase-cleaved tau colocalizes with tangles and correlates with the progression in Alzheimer's disease 15, 16 and in animal models of tauopathy 14, 17 . Both caspase 3 and caspase 6 have been implicated in this cleavage 5, 18, 19 . We repeated our in vivo imaging using caspase probes selective for caspase 6, caspase 3/7, and a pancaspase indicator. Both caspase 6 and caspase 3/7 probes, as well as the pan-caspase probe, co-localized with tangles in vivo. Immediately after in vivo imaging with the robust in vivo pan-caspase indicator, we sacrificed the animals and examined the brains using an antibody directed against the tau-D421 neoepitope. The bright fluorescent pan-caspase indicator always correlated with the presence of immunohistochemically defined tau truncated at D421 (Fig. 3a-c) . Thus, the caspase activation we observe in vivo is associated with generation of a truncated form of tau.
Intracerebral injections of adeno-associated virus (AAV)-vector encoding for wild-type tau-4R were performed in two wild-type mice (13 months old) and analysed 6 months later. We chose to use wildtype tau rather than the P301L mutant tau overexpressed in the Tg4510 mice because wild-type tau represents the situation in sporadic Alzheimer's disease, and most frontotemporal dementia. By in vivo imaging, 8 to 10 caspase-positive cells per brain were detected around the injection sites ( Supplementary Fig. 4 ), consistent with a recent study describing neurodegeneration after a comparable tau-4R virus infection 20 . On post-mortem tissue, the active caspase-positive cells correlated with the presence of caspase-cleaved tau (Fig. 3d-f) . Truncated tau was occasionally associated with Alz50-reactive neurons ( Supplementary Fig. 5a-c) . Caspase-truncated tau was similarly detected in 14-month-old hTau mice 21 that carry the non-mutated human tau gene (also known as MAPT) (Fig. 3h, i) . Taken together, these data confirm in three separate models (Tg4510 mice, wild-type mice overexpressing tau-4R and hTau mice) the hypothesis that soluble tau molecules trigger caspase activation that leads to tau truncation at D421.
Tau truncated products are prone to aggregation, and have been previously shown to augment nucleation efficiency directly and accelerate fibrillization of tau in vitro [22] [23] [24] . We propose that this cleavageinduced acceleration of nucleation and aggregation can also occur in vivo, leading to tangle formation in Tg4510 mice. We injected a virus encoding a construct of wild-type tau truncated at position 421 into wild-type mice to test the hypothesis that this form of truncated tau would seed aggregation in vivo. We found that about 35% of neurons expressing truncated tau developed accumulations of Alz50-positive immunoreactivity, representing conformational changes in tau in the cell body ( Supplementary Fig. 5d-f ). PHF1 and AT8-positive phosphorylation changes were also detected, indicating that the presence of truncated tau was sufficient to induce Alzheimer-like conformational and phosphorylation changes. Endogenous tau, immunolocalized with a carboxy-terminal antibody, was found to mislocalize to the cell body and colocalize with truncated tau in Alz50-positive structures (Fig. 4) . These data are reminiscent of the results observed by transgenic expression of a truncated tau fragment centred on the repeat domains, that developed aggregates containing endogenous mouse tau 25 . This is consistent with the idea that cleavage of tau (by caspase or non-caspase proteolysis 26, 27 ) precedes, and is sufficient to cause, misfolding of tau into a conformation that can nucleate and recruit additional tau molecules to the neuronal cell body.
Taken together, these data indicate that, rather than being the cause of neurodegenerative cascades, tau fibrillar deposits are the consequence of a cellular degenerative process marked by caspase activation (Supplementary Fig. 6 ). Tangles form quickly, in a time frame of hours-but persist apparently indefinitely. Tangles seem to always start in neurons that contain active caspases, but at a later time, the vast majority of tangle-positive neurons are not caspasepositive. Thus, direct visualization of caspase activation and tangle formation shows three results unanticipated from cross-sectional histopathological studies: (1) caspase activation precedes and leads to tangle formation over less than 24 h, (2) neurons can have activated caspases but not die acutely, and (3) on the basis of our in vivo imaging and the results of the long-term transgene suppression, tangles are long-lived species. Tangle-bearing neurons may represent survivors of an attack of enzymes usually associated with acute apoptotic death and, therefore, represent a marker, rather than a direct cause, of neurodegenerative processes. How neurons survive caspase activation, and whether tangles are a protective factor, a simple bystander, or are associated with slow or delayed toxic effects will be important questions to address as therapeutics aimed at tangle formation enter clinical trials.
METHODS SUMMARY
Animals. We used 7-9-month-old transgenic Tg4510 mice overexpressing human four-repeat tau gene containing the frontotemporal dementia-associated P301L mutation that can be suppressed with doxycycline 7 . By 7 months of age, Tg4510 mice have developed a large number of tangles in the cortex. Surgery and imaging. Tg4510 mice and littermate controls were anaesthetized with isoflurane, a craniotomy was performed, and thioflavin S and caspase indicators (FLICA, fluorescent inhibitor of caspase reagent; Invitrogen) applied topically before sealing the craniotomy with a coverslip. In vivo multiphoton microscopy was used to image living neurons, existing tangles, activated caspases and formation of new tangles 9, 10 . Viral injection. Intracranial injection of an adeno-associated virus (AAV2) encoding human tau-4R was performed on two non-transgenic animals at 13 months of age, and left for 6 months. Similarly, an AAV2 encoding human tau truncated at aspartate 421 was performed on three non-transgenic animals at 13 months of age, and left for 10 weeks. Post-mortem studies were carried out by immunohistochemistry on fixed frozen sections.
All animal experiments were carried out under national (United States National Institutes of Health) and institutional guidelines (Massachusetts General Hospital subcommittee for research animal care).
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature. 
